Skip to main content

Laura Donadeu Casassas

Institutions of which they are part

Main researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Laura Donadeu Casassas

Institutions of which they are part

Main researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Projects

Caracterización de la respuesta inmune celular específica frente al virus Epstein-Barr en receptores de trasplante renal pediátrico (CRICE-VEB)).

IP: -
Collaborators: Gema Ariceta Iraola, Laura Donadeu Casassas, Delphine Kervella
Funding agency: Sociedad Española de Trasplantes
Funding: 20000
Reference: SET/AYUDAS.PROYECTOS/2023/LOPEZ
Duration: 01/01/2024 - 31/12/2025

RESETTING THE IMMUNOLOGICAL SYSTEM OF HYPERSENSITIZED TRANSPLANT CANDIDATES TO ALLOW ACCESS TO HLA COMPATIBLE KIDNEY TRANSPLANTATION (RESET TRIAL)

IP: Oriol Bestard Matamoros
Collaborators: Ana Pérez González, Franc Casanova Ferrer, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, Clàudia Carrera Muñoz, Maria Antonia Emilia Meneghini, Delphine Kervella
Funding agency: Instituto de Salud Carlos III
Funding: 465456.69
Reference: ICI24/00066
Duration: 01/01/2025 - 31/12/2029

Assessment of natural antibodies in solid organ transplant

IP: Laura Donadeu Casassas
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 20700
Reference: MV23/00037
Duration: 16/09/2024 - 13/12/2024

Disección y promoción de inmunidad adaptativa específica frente al poliomavirus (BKV) para prevenir la infección viral tras el trasplante renal (proyecto BK-VAX).

IP: Oriol Bestard Matamoros
Collaborators: Juliana Esperalba Esquerra, Joana Sellarés Roig, Emma Pardo De los Santos, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, Narcís Saubí Roca
Funding agency: Instituto de Salud Carlos III
Funding: 174240
Reference: PI22/01019
Duration: 01/01/2023 - 31/12/2025

Related news

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

Related professionals

Jose Maria  Zuazo  Morquecho

Jose Maria Zuazo Morquecho

Liver Diseases
Read more
Vazquez Sanchez, Angel

Vazquez Sanchez, Angel

Maintenance staff and general services
Cardiovascular Diseases
Read more
Luís Gros Subias

Luís Gros Subias

Childhood Cancer and Blood Disorders
Read more
Lopez Mañas, Elena

Lopez Mañas, Elena

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.